Related Experiment Video
Updated: Jun 27, 2026

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Sodium orthovanadate affects growth of some human epithelial cancer cells (A549, HTB44, DU145)
Andrzej Klein1, Przemyslaw Holko, Janusz Ligeza
1Department of General Biochemistry, Faculty ofBiochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.
Abstract:
Within the concentration range of 1-20 microM, orthovanadate (Na3VO4) demonstrated a time and dose-dependent inhibition of autocrine growth of the human carcinoma cell lines A549 (lung), HTB44 (kidney) and DU145 (prostate), as compared to appropriate controls (without Na3VO4). The investigation was conducted by two methods: staining with N-hexa-methylpararosaniline (crystal violet=CV) or bromide3-(4,5-dimethyltio-azo-2)-2,5-diphenyl-tetrazole (MTT). In 5, 10 and 20 microM of Na3VO4 in serum-free medium, the mean values of these two tests for A549 were approximately 40%, 45% or 65% as compared to the appropriate controls. HTB44 had the greatest opportunity (statistically insignificant) at lower vanadium concentrations (up to 10 microM), whereas at 20 microM growth inhibition of these cells was approximately 50% of the controls. DU145 showed approximately 33%, 65% and 98% growth inhibition for 5, 10 and 20 microM of Na3VO4, respectively Additionally, hypothetical curves obtained by a MANOVA test based on the CV results after 72 h incubation with Na3VO4 in serum-free medium, and an example of a time-dependent effect of Na3VO4 on A549 cells, were also presented. Sodium orthovanadate was also examined for its cytotoxic capabilities, especially its ability to induce tumor cell apoptosis; the results were compared with the effect of paclitaxel. The target cells were dyed by differential staining (HOECHST33258 and propidium iodide) after 3 h and 24 h (DU145) or 3 h and 72 h (A549) of incubation with the vanadium compound. Contrary to the two cancer cell lines (viable, apoptotic or necrotic in experimental conditions), the renal HTB44 cells were insensitive up to 15 microM Na3VO4 concentrations. After 3 h incubation with Na3VO4, both lung (A549) and prostate (DU145) cancer cells showed a slight but significant reduction in the percentage of viable cells, and an increased amount of apoptotic cells. In contrast to the lung cells, DU145 prostate cells after 24 h were more sensitive to paclitaxel than to sodium orthovanadate. In the case of lung cells, the time of incubation was prolonged (to 72 h) to allow for a study of the effect of orthovanadate in greater detail. After 72 h of incubation with Na3VO4 or paclitaxel, A549 showed a similar level of viable cells (25-32% of total cultured cells); however, the percentage of apoptotic cells was higher in the case of A549 cells--ca 36% for both drugs, but the concentration of Na3VO4 was significantly greater than paclitaxel levels.
Insights
Sodium orthovanadate (Na3VO4) inhibits the growth of human lung, kidney, and prostate cancer cells in a dose-dependent manner. It also induces apoptosis in lung and prostate cancer cells, showing potential as an anti-cancer agent.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Cancer cell growth is a complex process involving autocrine signaling pathways.
- Novel therapeutic agents are continuously being investigated to target cancer cell proliferation and induce apoptosis.
- Orthovanadate compounds have shown promise in preclinical cancer research.
Purpose of the Study:
- To investigate the effect of sodium orthovanadate (Na3VO4) on the autocrine growth of human carcinoma cell lines A549 (lung), HTB44 (kidney), and DU145 (prostate).
- To evaluate the cytotoxic capabilities of Na3VO4, including its ability to induce tumor cell apoptosis.
- To compare the effects of Na3VO4 with paclitaxel in specific cancer cell lines.
Main Methods:
- Cell viability assays using N-hexa-methylpararosaniline (crystal violet) and bromide3-(4,5-dimethyltio-azo-2)-2,5-diphenyl-tetrazole (MTT).
- Differential staining with HOECHST33258 and propidium iodide to assess apoptosis and necrosis.
- Statistical analysis including MANOVA test for time-dependent effects.
Main Results:
- Na3VO4 demonstrated time- and dose-dependent inhibition of A549, HTB44, and DU145 cell growth within the 1-20 microM range.
- DU145 cells showed the highest sensitivity to Na3VO4, with approximately 98% growth inhibition at 20 microM.
- Na3VO4 induced apoptosis in A549 and DU145 cells, with varying sensitivity compared to paclitaxel depending on cell type and incubation time.
Conclusions:
- Sodium orthovanadate exhibits significant anti-proliferative and pro-apoptotic effects on human lung and prostate cancer cells.
- Renal HTB44 cells showed relative insensitivity to Na3VO4 up to 15 microM concentrations.
- Na3VO4 represents a potential therapeutic agent for certain cancers, warranting further investigation, particularly in comparison to established chemotherapeutics like paclitaxel.
